首页> 外文期刊>Biomaterials >Bioengineering endothelialized neo-corneas using donor-derived corneal endothelial cells and decellularized corneal stroma.
【24h】

Bioengineering endothelialized neo-corneas using donor-derived corneal endothelial cells and decellularized corneal stroma.

机译:使用供体来源的角膜内皮细胞和脱细胞的角膜基质生物工程化内皮新角膜。

获取原文
获取原文并翻译 | 示例
           

摘要

Corneal transplantation is a common transplant procedure performed to improve visual acuity by replacing the opaque or distorted host tissue by clear healthy donor tissue. However, its clinical utility is limited due to a lack of high quality donor corneas. Bioengineered neo-corneas, created using an expandable population of human donor-derived corneal endothelial cells (HCEC), could address this current shortage. The objectives of this study were to establish HCEC isolation and culture protocols and to investigate the feasibility of bioengineering corneal tissue constructs by seeding the cells on decellularized human corneal stroma. HCECs were removed from the discarded corneas of eye donors by enzymatic digestion. Cells were expanded and evaluated for their expression of Na(+)/K(+)-ATPase and zona occludens-1 (ZO-1). Donor corneal stromas were cut to 120-200 microm thickness slices using a microtome and then decellularized. Extracellular matrix components and mechanical properties of the scaffolds were measured after decellularization. To engineer neo-corneas, 130 HCEC/mm(2) were seeded on decellularized human corneal stromas. The resulting constructs were placed in growth medium for 14 days and then analyzed using scanning electron microscopy (SEM), histology, and immunocytochemistry. Seeded cells retain expression of the functional markers Na(+)/K(+)-ATPase and ZO-1 and constructs have biomechanical properties similar to those of normal corneas. These results indicate that construction of neo-corneas, using HCECs derived from discarded donor corneas and decellularized thin-layer corneal stromas, may create a new source of high quality corneal tissue for transplantation.
机译:角膜移植是通过用透明的健康供体组织代替不透明或扭曲的宿主组织来改善视敏度的常用移植程序。然而,由于缺乏高质量的供体角膜,其临床应用受到限制。生物工程化的新角膜使用可扩展的人类供体来源的角膜内皮细胞(HCEC)群体产生,可以解决当前的短缺问题。这项研究的目的是建立HCEC分离和培养方案,并通过将细胞接种在脱细胞的人角膜基质上来研究生物工程化角膜组织构建体的可行性。 HCEC通过酶消化从废弃的眼供体角膜中去除。扩大细胞并评估其Na(+)/ K(+)-ATPase和透明带遮盖物1(ZO-1)的表达。使用切片机将供体角膜基质切成120-200微米厚的切片,然后脱细胞。脱细胞后测量支架的细胞外基质成分和机械性能。为了工程化新角膜,将130 HCEC / mm(2)播种在脱细胞的人类角膜基质上。将得到的构建体在生长培养基中放置14天,然后使用扫描电子显微镜(SEM),组织学和免疫细胞化学进行分析。种子细胞保留功能标记Na(+)/ K(+)-ATPase和ZO-1的表达,并且构建体具有与正常角膜相似的生物力学特性。这些结果表明,使用源自废弃供体角膜和脱细胞的薄层角膜基质的HCEC构建新角膜,可能会为移植的高质量角膜组织创造新的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号